Inventor · disambiguated record
Donna A. A. Wilton
Also filed as: WILTON DONNA · WILTON DONNA A A
11 granted patents·2 pending applications·5 citations·filing 2013–2021
82Inventor score
Top patents by PatentIndex Score
13 records- 0189US10961267B2Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Mar 30, 2021·3 cites·18 claims
- 0275US10472366B2Glucuronide prodrugs of tofacitinibTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Nov 12, 2019·1 cites·37 claims
- 0372US11608354B2Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Granted Mar 21, 2023·0 cites·11 claims
- 0470US9593110B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2015·Granted Mar 14, 2017·1 cites·25 claims
- 0561US10005740B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jun 26, 2018·0 cites·1 claims
- 0661US2021032250A1Glucuronide prodrugs of janus kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Application pending·0 cites
- 0760US9783507B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Oct 10, 2017·0 cites·1 claims
- 0859US10745405B2Glucuronide prodrugs of Janus kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 18, 2020·0 cites·31 claims
- 0955US10435428B2Prodrugs of a JAK inhibitor compound for treatment of gastrointestinal inflammatory diseaseTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Oct 8, 2019·0 cites·14 claims
- 1055US2018193338A1Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Application pending·0 cites
- 1152US9839639B2Neprilysin inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Dec 12, 2017·0 cites·22 claims
- 1246US9585882B2Neprilysin inhibitorsFLEURY MELISSA·Filed 2015·Granted Mar 7, 2017·0 cites·24 claims
- 1342US9206159B2Piperazine-piperidine compounds as hepatitis C virus inhibitorsLONG DANIEL D·Filed 2013·Granted Dec 8, 2015·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →